Puma Biotech: Q4 Earnings Snapshot

LOS ANGELES (AP) — LOS ANGELES (AP) — Puma Biotechnology Inc. (PBYI) on Thursday reported profit of $12.3 million in its fourth quarter.

The Los Angeles-based company said it had net income of 26 cents per share. Earnings, adjusted for stock option expense, were 31 cents per share.

The biopharmaceutical company posted revenue of $72.2 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $73.2 million.

For the year, the company reported profit of $21.6 million, or 45 cents per share. Revenue was reported as $235.6 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI